-
Future intervention trials in type 1 diabetes.
Diabetes CareWilkin T, Ludvigsson J, Greenbaum CJ, Palmer JP, Becker D, Bruining J -
MHC Class II tetramers and the pursuit of antigen-specific T cells: define, deviate, delete.
Clin ImmunolMallone R, Nepom GT -
Absence of an essential role for thymic stromal lymphopoietin receptor in murine B-cell development.
Mol Cell BiolCarpino N, Thierfelder WE, Chang MS, Saris C, Turner SJ, Ziegler SF, Ihle JN -
Systematic screening of potential beta-cell imaging agents.
Biochem Biophys Res CommunSweet IR, Cook DL, Lernmark A, Greenbaum CJ, Wallen AR, Marcum ES, Stekhova SA, Krohn KA -
Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1.
BloodLandais E, Saulquin X, Scotet E, Trautmann L, Peyrat MA, Yates JL, Kwok WW, Bonneville M, Houssaint E -
HLA class II polymorphisms determine responses to bacterial superantigens.
J ImmunolLlewelyn M, Sriskandan S, Peakman M, Ambrozak DR, Douek DC, Kwok WW, Cohen J, Altmann DM -
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.
DiabetesPalmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW -
Regulating the immune system: the induction of regulatory T cells in the periphery.
Arthritis Res TherBuckner JH, Ziegler SF -
Transcription factors in autoimmunity.
Curr Opin ImmunolRamsdell F, Ziegler SF -
Detection of CD4+ autoreactive T cells in T1D using HLA class II tetramers.
Ann N Y Acad SciReijonen H, Kwok WW, Nepom GT -
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.
J Clin InvestWalker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH, Ziegler SF -
Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2.
J VirolIyasere C, Tilton JC, Johnson AJ, Younes S, Yassine-Diab B, Sekaly RP, Kwok WW, Migueles SA, Laborico AC, Shupert WL, Hallahan CW, Davey RT Jr, Dybul M, Vogel S, Metcalf J, Connors M -
HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination.
J ImmunolDanke NA, Kwok WW -
CD69-null mice protected from arthritis induced with anti-type II collagen antibodies.
Int ImmunolMurata K, Inami M, Hasegawa A, Kubo S, Kimura M, Yamashita M, Hosokawa H, Nagao T, Suzuki K, Hashimoto K, Shinkai H, Koseki H, Taniguchi M, Ziegler SF, Nakayama T -
Scurfin (FoxP3) controls T-dependent immune responses in vivo through regulation of CD4+ T cell effector function.
J ImmunolKasprowicz DJ, Smallwood PS, Tyznik AJ, Ziegler SF
